A case of late-life onset mania during Varenicline assisted smoking cessation

International Journal of Geriatric Psychiatry

Volumn 26, Issue 6, 2011, Pages 658-659

  Francois, Dimitry ^a   Odom, Anna ^a   Kotbi, Nabil ^a  

^a College of Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE; VALPROATE SEMISODIUM; VARENICLINE;

AGED; AGITATION; CASE REPORT; DEPRESSION; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; GRANDIOSE DELUSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INSOMNIA; LETTER; MALE; MANIA; PATIENT COMPLIANCE; SIDE EFFECT; SMOKING CESSATION; SPEECH RATE; TREATMENT DURATION;

AGE OF ONSET; AGED; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZAZEPINES; BIPOLAR DISORDER; HUMANS; MALE; NICOTINIC AGONISTS; QUINOXALINES; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 79953835488     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2615     Document Type: Letter

References (17)

1. Alhatem F, Black JE,. 2009. Varenicline-induced mania in a bipolar patient. Clin Neuropharmacol. 32 (2): 117-118.
2. Baran X, Docherty J,. 2010. Rapid and sustained response to a single dose of sertraline in a patient with newly emergent depression during varenicline-assisted smoking cessation. CNS Spectr 15: 3.
3. DiPaula B, Thomas M,. 2009. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. Pharmacotherapy 29 (7): 852-857.
4. Depp C, Jeste D,. 2004. Bipolar disorder in older adults: a critical review. Bipolar Disord 6: 343-367. (Pubitemid 39345286)
5. FDA Alert of 2/1/2008.
6. FDA: boxed warning on serious mental health events. July 2009.
7. Gerner RH, Post RM, Bunney WE,. 1976. Dopaminergic mechanism in mania. Am J Psychiatry 133: 1177-1180.
8. Kohen I,. 2007. Varenicline-induced manic episode in a patient with bipolar disorder. Am J Psychiatry 164: 8.
9. Merikangas KR, Akiskal HS, Angst J, et al,. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry 64 (5): 543-552. (Pubitemid 46718287)
10. Morstad AE, Kutscher EC, Kennedy WK, et al,. 2008. Hypomania with agitation associated with varenicline use in bipolar II disorder. Ann Pharmacother 42: 288-289. (Pubitemid 351238580)
11. Rollema H, Chambers LK, Coe JW, et al,. 2007. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52: 985-994. (Pubitemid 46227486)
12. Sanacora G, Zarate C, Krystal J, Manji H,. 2008. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7 (5): 426-437. (Pubitemid 351619114)
13. Schroeder SA,. 2009. A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA 301 (5): 522-531.
14. Sharp T, Zetterstrom T, Ljungberg T, Ungerstedt U,. 1987. A direct comparison of amphetamine-induced behaviors and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 401: 322-330. (Pubitemid 17221822)
15. Tsoh J, Humfleet G, Muñoz R, et al,. 2000. Development of major depression after treatment for smoking cessation. Am J Psychiatry 157: 368-374. (Pubitemid 30145921)
16. Weissman M, Leaf P, Tischler G, et al,. 1988. Affective disorders in five U.S. communities. Psychol Med 18: 141-153. (Pubitemid 18071642)
17. Young R, Klerman G,. 1992. Mania in late life: Focus on age at onset. Am J Psychiatry 149: 7.